pre-update Archives

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

Certara2020 年 8 月 7 日

Publication

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…

Certara2020 年 7 月 26 日

Publication

模型引导的药物再利用：Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19

We hypothesized that viral kinetic modeling could be helpful to prioritize rational drug combinations for…

Certara2020 年 7 月 26 日

Article

PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue

Certara2020 年 7 月 20 日

Publication

Salvaging CNS Clinical Trials Halted Due to COVID‐19

The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical…

Certara2020 年 7 月 15 日

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

Certara2020 年 7 月 14 日

Publication

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…

Certara2020 年 7 月 14 日

SDTM Supplemental Qualifiers - blog post by Certara

On-Demand Webinar

The supplementary domain in SDTM: good, bad and ugly

All you need to know about the supplementary domain in SDTM The supplementary domain in…

Certara2020 年 7 月 2 日

Publication

VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays

Certara2020 年 6 月 28 日

On-Demand Webinar

Simcyp：20 年的创新

Certara2020 年 6 月 27 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

pre-update

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

模型引导的药物再利用：Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19

PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue

Salvaging CNS Clinical Trials Halted Due to COVID‐19

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

The supplementary domain in SDTM: good, bad and ugly

VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays

Simcyp：20 年的创新

订阅时事通讯

快捷链接

解决方案

联系我们